Keywords:
AI-based drug discovery; antibiotic-resistant bacteria; machine learning; cheminformatics; molecular docking; statistical analysis
Abstract
The emergence of antibiotic-resistant bacteria represents a critical threat to global public health, necessitating innovative approaches to drug discovery. Artificial Intelligence (AI) has emerged as a transformative tool in identifying novel compounds and predicting their biological activity against resistant pathogens. This manuscript provides an overview of AI-based methodologies for drug discovery targeting antibiotic-resistant bacteria, reviewing literature up to 2021. We discuss key algorithms, data-driven strategies, and integrated pipelines that combine cheminformatics, molecular docking, and machine learning. A statistical analysis is presented to compare the efficacy of different AI models, followed by a detailed description of our methodology, results, and insights from recent case studies. Finally, the manuscript concludes with a discussion on the potential impact of AI in accelerating the drug discovery process, while outlining future directions for research that could further refine these approaches.
References
- https://www.google.com/url?sa=i&url=https%3A%2F%2Fappinventiv.com%2Fblog%2Fai-in-drug-discovery%2F&psig=AOvVaw12em3EywRJe6ShxbUN4j9Q&ust=1741702899535000&source=images&cd=vfe&opi=89978449&ved=0CBQQjRxqFwoTCMibn43g_4sDFQAAAAAdAAAAABAE
- https://www.google.com/url?sa=i&url=https%3A%2F%2Fwww.frontiersin.org%2Fjournals%2Fmicrobiology%2Farticles%2F10.3389%2Ffmicb.2024.1347000%2Ffull&psig=AOvVaw1g2iZREuUPQExBzNwSt_lY&ust=1741704501637000&source=images&cd=vfe&opi=89978449&ved=0CBQQjRxqFwoTCIjKxY3h_4sDFQAAAAAdAAAAABAJ
- Anderson, B., Li, H., & Kumar, S. (2018). Regulatory and ethical considerations in AI-based drug discovery. Drug Discovery Today, 23(10), 1598–1605.
- Allen, T., & Roberts, M. (2021). Recent advances in AI applications for drug discovery. Expert Review of Molecular Diagnostics, 21(3), 275–286.
- Brown, N., & Ertl, P. (2019). Applications of machine learning in drug discovery. Journal of Cheminformatics, 11(1), 32.
- Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., & Blaschke, T. (2018). The rise of deep learning in drug discovery. Drug Discovery Today, 23(6), 1241–1250.
- Davis, J., & Chen, D. (2020). AI methodologies in drug repurposing for infectious diseases. Frontiers in Pharmacology, 11, 123.
- Gupta, R., & Kaur, H. (2021). Deep learning in molecular docking and drug design. Journal of Chemical Information and Modeling, 61(3), 1422–1430.
- Kim, H., Park, S., & Lee, J. (2018). Machine learning applications in identifying novel antibiotics. Journal of Molecular Modeling, 24(6), 123.
- Liu, J., Wang, L., & Zhao, Q. (2020). Integration of cheminformatics and AI for antimicrobial drug discovery. Bioinformatics, 36(8), 2528–2534.
- Martin, E., Thompson, R., & Patel, S. (2017). Machine learning in the design of new antibiotics. Bioorganic & Medicinal Chemistry, 25(24), 6677–6684.
- Miller, C., Johnson, D., & Rivera, M. (2019). Data integration in antibiotic resistance research: AI perspectives. BioMed Research International, 2019, Article ID 7891620.
- Morgan, S. L., Lee, K., & White, J. (2018). The application of AI for antibacterial drug discovery. Journal of Antibiotics, 71(9), 1157–1166.
- O’Connor, S., Zhang, Y., & Ramirez, P. (2019). Bridging cheminformatics and bioinformatics using AI. Computational Biology and Chemistry, 81, 100–107.
- Patel, A., & Gupta, S. (2019). Computational approaches to drug discovery: A review. Current Pharmaceutical Design, 25(29), 3072–3082.
- Rivera, M., Singh, R., & Brown, L. (2020). AI-driven molecular docking in drug discovery. Journal of Computer-Aided Molecular Design, 34(2), 155–165.
- Roberts, D., Nguyen, T., & Miller, A. (2017). Molecular fingerprinting and machine learning for antibiotic discovery. ACS Chemical Biology, 12(10), 2421–2428.
- Singh, R., & Kumar, A. (2019). A review on the use of AI in combating antibiotic resistance. Expert Opinion on Drug Discovery, 14(6), 501–511.
- Tan, K., Wong, P., & Lim, Y. (2020). Advances in QSAR modeling for antibacterial agents. European Journal of Medicinal Chemistry, 187, 111949.
- Williams, J., Davis, R., & Thompson, L. (2020). AI and high-throughput screening in drug discovery. Nature Reviews Drug Discovery, 19(11), 789–803.
- Zhao, Q., Li, X., & Chen, M. (2018). Predicting antimicrobial activity using machine learning models. PLOS ONE, 13(7), e0200525.
- Zhang, Y., Chen, P., & Wang, J. (2020). AI-powered drug repurposing: Accelerating discovery for infectious diseases. Journal of Medicinal Chemistry, 63(14), 8028–8035.
How to cite
Shweta Kumari (2023). AI-Based Drug Discovery for Antibiotic-Resistant Bacteria. International Journal for Research in Management & Pharmacy, 12(10), 1-8. https://doi.org/10.63345/ijrmp.v12.i10.1
Licence
This article is open access, published under the CC BY 4.0 licence. Copyright remains with the authors.
If the issue persists, you can use the old publisher details where you get it published.